BrightPath Biotherapeutics Co (TSE:4594) Price-to-Operating-Cash-Flow : (As of May. 14, 2024)

BrightPath Biotherapeutics Co Price-to-Operating-Cash-Flow Chart

BrightPath Biotherapeutics Co Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
Price-to-Operating-Cash-Flow		Get a 7-Day Free Trial				-	-	-	-	-

BrightPath Biotherapeutics Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of BrightPath Biotherapeutics Co's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, BrightPath Biotherapeutics Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BrightPath Biotherapeutics Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BrightPath Biotherapeutics Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where BrightPath Biotherapeutics Co's Price-to-Operating-Cash-Flow falls into.

BrightPath Biotherapeutics Co Price-to-Operating-Cash-Flow Calculation

BrightPath Biotherapeutics Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

BrightPath Biotherapeutics Co's Share Price of today is 円57.00.
BrightPath Biotherapeutics Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

BrightPath Biotherapeutics Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of BrightPath Biotherapeutics Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

BrightPath Biotherapeutics Co (TSE:4594) Business Description